This new oncolytic adenovirus mutant has good clinical prospect in gene curing so to used in curing many kinds of human tumors.
该新型溶瘤腺病毒突变体在基因治疗中具有良好的临床应用前景，可用于多种人体肿瘤的治疗。
Objective:To evaluate the selectively oncolytic effect of conditionally replicating adenovirus CNHK500 in breast cancer.
目的：观察选择性增殖腺病毒CNHK500对乳腺癌的特异性杀伤作用。
Objective:To evaluate the selectively oncolytic effect of conditionally replicating adenovirus CNHK500 in breast cancer.
目的：观察选择性增殖腺病毒CNHK500对乳腺癌的特异性杀伤作用。
应用推荐